October 2021

 
 

A new look

WHO / Sergey Volkov

Welcome to our new newsletter format!

Interesting and informative news from our trusted teams around the world delivered to your inbox. Enjoy and feel free to share; we value every subscriber. 

 

© WHO / Tom Pietrasik

Flu is on the rise

Influenza is on the rise; how do I prevent it?

Find out more
 

© WHO / Blink Media - Hannah Reyes Morales

COVID-19 and Influenza -similarities and differences

A recently updated Q&A provides the answers and stresses the importance of vaccination against both COVID-19 and influenza

Find out more
 

Flickr/Alberta Newsroom (CC BY-NC-ND 2.0)

Shots for success

WHO has issued recommendations on the composition of influenza vaccines for the next Southern hemisphere flu season in 2022.

Find out more
 

© WHO / Egor Dubrovsky

Fundamentals first

The annual Bi Regional WPRO SEARO meeting of influenza surveillance and National Influenza Centres (NICs) calls for continuous and consistent flu monitoring, while integrating COVID-19 surveillance.

Find out more
 

© WHO / Tom Pietrasik

Ready, set, PIP

Countries in South-East Asia have made substantial gains in pandemic influenza preparedness despite COVID-19 disruption. And they are ready for more in the year ahead. 

Find out more
 

© WHO/FluNet

FluNet becomes more interactive with SARS-CoV-2 data now included

If you like exploring interactive outputs on influenza detections, check out the visualizations that now have SARS-CoV-2 surveillance data included. You can follow the trends in SARS-CoV-2 testing and positivity by WHO region over time according to data reported from countries who are testing routine respiratory surveillance samples for both influenza and SARS-CoV-2 following WHO guidance.

Find out more
 

Unveiling the Influenza Vaccines Research and Development Roadmap

A new global effort to improve seasonal influenza vaccines and accelerate broadly protective or universal influenza vaccine development was launched on September 30, 2021. The Roadmap, which is the culmination of 2 years of engagement with more than 100 organizations in 29 countries, identifies strategic goals across six key areas.

Find out more
 

© WHO

New GISRS and GISAID training series rolled out

The bioinformatics workshops aim to strengthen GISRS genomic surveillance and will improve virus sequencing and the effective use of GISAID tools. Stay tuned for more in the next newsletter.

 

Upcoming meetings

2nd global virtual consultation on the integrated sentinel surveillance of influenza and SARS-CoV-2 
12 to 14 October 2021
To update interim guidance on integrated surveillance of influenza and SARS-CoV-2, incorporating the sequencing guidance on SARS-CoV-2 for GISRS, document country best practices, and finalize the GISRS Pandemic Response Plan and GISRS Plus roadmap.  

10th virtual meeting of the WHO Working Group on Surveillance of Antiviral Susceptibility of Influenza Viruses for GISRS (AVWG) 
2 to 4 November 2021
To review data on circulating influenza viruses resistance to approved antiviral drugs, improvements to surveillance, new antivirals and methods to detect viruses, and improvements to drug resistance testing.

 

Publications

PIP AG 2020 Annual Report
September

Leveraging influenza capacity and systems to respond to COVID-19, Weekly Epidemiological Record, 2021, vol. 96
September

 
Website
 
 

General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

 

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

 

All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use.

Preferences  |  Unsubscribe